Imipenem-resistant acinetobacter baumannii carrying the ISABA1-BLAOXA-23, 51 and ISABA1-BLAADC-7 genes in Monteria, Colombia

Brazilian Journal of Microbiology

Volumn 43, Issue 4, 2012, Pages 1274-1280

  Martínez, Pedro ^a   Mattar, Salim ^a  

^a UNIVERSIDAD DE CÓRDOBA   (Colombia)

Author keywords

Antimicrobial resistance; Nosocomial pathogens; PFGE

Indexed keywords

EID: 84874372682     PISSN: 15178382     EISSN: 16784405     Source Type: Journal    
DOI: 10.1590/S1517-83822012000400006     Document Type: Article

References (34)

1. Altschul, S.; Gish, W.; Miller, W.; Myers, E.; Lipman, D. (1990). Basic local alignment search tool. J. Mol. Biol. 215 (3), 403-410.
2. Ben Othman, A.; Zribi, M.; Masmoudi, A.; Abdellatif, S.; Ben Lakhal, S.; Fendri, C. (2011). Multiresistance and endemic status of Acinetobacter baumannii associated with nosocomial infections in a tunisian hospital: a critical situation in the intensive care units. Braz. J. Microbiol. 42 (2), 415-422.
3. Brenner, P.; Otaíza, F.; Bustamante, R. (2004). Nosocomial infections outbreaks in Chile 1985-2002. Am. J. Infect. Control. 32 (3), E49.
4. Clinical and Laboratory Standards Institute (CLSI). (2009). Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Informational. Eighth ed. Approved standard M7-A8. Wayne, PA, EE.UU. Clinical and Laboratory Standards Institute.
5. Corvec, S.; Caroff, N.; Espaze, E.; Giraudeau, C.; Drugeon, H.; Reynaud, A (2003). AmpC cephalosporinase hyperproduction in Acinetobacter baumannii clinical strains. J. Antimicrob. Chemother. 52 (4), 629-635.
6. Dalla Costa, L.; Coelho, J.; Souza, H.; Castro, M.; Stier, C.; Bragagnolo, K.; Rea Neto, A.; Penteado Filho, S.; Livermore, D.; Woodford, N. (2003). Outbreak of carbapenem-resistant Acinetobacter baumannii producing OXA-23 enzymes in Curitiba, Brazil. J. Clin. Microbiol. 41 (7), 3403-3406.
7. Fagon, J.; Chastre, J.; Domart, Y.; Trouillet, J.; Gibert, C. (1996). Mortality due to ventilator-associated pneumonia or colonization with Pseudomonas or Acinetobacter species: assessment by quantitative culture of samples obtained by a protected specimen brush. Clin. Infect. Dis. 23 (3), 538-542.
8. Fernández Cuenca, F.; Martínez Martínez, L.; Conejo, M.; Ayala, J.; Perea, E.; Pascual, A. (2003). Relationship between β-lactamase production, outer membrane protein and penicillin-binding protein profiles on the activity of carbapenems against clinical isolates of Acinetobacter baumannii. J. Antimicrob. Chemother. 51 (3), 565-574.
9. García, J.; Ortiz, C.; Garnacho, J.; Jiménez Jiménez, F.; Pérez Paredes, C.; Barrero Almodóvar, A.; Miner, M. (2001). Risk factors for Acinetobacter baumannii nosocomial bacteremia in critically ill patients: a cohort study. Clin. Infect. Dis. 33 (7), 939-946.
10. Gaspareto, P.; Martins, A.; Zavascki, A.; Barth, A. (2007). Ocurrence of blaSPM-1 and blaIMP-1 genes of metallo-beta-lactamases in clinical isolates of Pseudomonas aeruginosa from three universitary hospitals in the city of Porto Alegre, Brazil. Braz. J. Microbiol. 38 (1), 108-109
11. Go, E.; Urban, C.; Burns, J.; Kreiswirth, B.; Eisner, W.; Mariano, N.; Mosinka Snipas, K.; Rahal, J. (1994). Clinical and molecular epidemiology of Acinetobacter infections sensitive only to polymyxin B and sulbactam. Lancet. 344 (8933), 1329-1332.
12. Guzmán Blanco, M.; Casellas, J.; Sader, H. (2000). Bacterial resistance to antimicrobial agents in Latin America. The patient is awakening. Infect. Dis. Clin. North. Am. 14 (1), 67-81.
13. Héritier, C.; Poirel, L.; Nordmann, P. (2006). Cephalosporinase over-expression resulting from insertion of ISAba1 in Acinetobacter baumannii. Clin. Microbiol. Infect. 12 (2), 123-130.
14. Hujer, K.; Hamza, N.; Hujer, A.; Perez, F.; Helfand, M.; Bethel, C.; Thomson, J.; Anderson, V.; Barlow, M.; Rice, L.; Tenover, F.; Bonomo, R. (2005). Identification of a new allelic variant of the Acinetobacter baumannii cephalosporinase, ADC-7 b-lactamase: defining a unique family of class C enzymes. Antimicrob. Agents. Chemother. 49 (7), 2941-2948.
15. Iyobe, S.; Minami, S.; Yamada, H. (1996). Insertion of a carbapenemase gene cassette into an integron of a Pseudomonas aeruginosa plasmid. J. Antimicrob. Chemother. 38 (6), 1114-1115.
16. Livermore, D. (2002). The impact of carbapenemases on antimicrobial development and therapy. Curr. Opin. Investig. Drugs. 3, 218-224.
17. Poirel, L.; Cabanne, L.; Vahaboglu, H.; Nordmann, P. (2005). Genetic Environment and Expression of the Extended-Spectrum β-Lactamase blaPER-1 Gene in Gram-Negative Bacteria. Antimicrob. Agents. Chemother. 49 (5), 1708-1713.
18. Poirel, L.; Marqué, S.; Héritier, C.; Segonds, C.; Charbanon, G.; Nordmann, P. (2005). OXA-58, a Novel Class D β-Lactamase Involved in Resistance to Carbapenems in Acinetobacter baumannii. Antimicrob. Agents. Chemother. 49 (1), 202-208.
19. Queenan, A.; Bush, K. (2007). Carbapenemases: the Versatile β-Lactamases. Clin. Microbiol. Rev. 20 (3), 440-458.
20. Ruiz, M.; Marti, S.; Fernandez Cuenca, F.; Pascual, A.; Vila, J. (2007). High prevalence of carbapenem-hydrolysing oxacillinases in epidemiologically related and unrelated Acinetobacter baumannii clinical isolates in Spain. Clin. Microbiol. Infect. 13 (12), 1192-1198.
21. Ruiz, M.; Marti, S.; Fernandez Cuenca, F.; Pascual, A.; Vila, J. (2007). Prevalence of ISAba1 in epidemiologically unrelated Acinetobacter baumannii clinical isolates. FEMS. Microbiol. Lett. 274 (1), 63-66.
22. Segal, H.; Garny, S.; Elisha, B. (2005). Is ISAba-1 customized for Acinetobacter? FEMS. Microbiol. Lett. 243, 425-429.
23. Segal, H.; Nelson, E.; Elisha, B. (2004). Genetic environment and transcription and transcription of AmpC in Acinetobacter baumannii clinical isolate. Antimicrob. Agents. Chemother. 48 (2), 612-614.
24. Seifert, H.; Dolzani, L.; Bressan, R.; van der Reijden, T.; van Strijen, B.; Stefanik, D.; Heersma, H.; Dijkshoorn, L. (2005). Standardization and Interlaboratory Reproducibility Assessment of Pulsed-Field Gel Electrophoresis-Generated Fingerprints of Acinetobacter baumannii. J. Clin. Microbiol. 43 (9), 4328-4335.
25. Siroy, A.; Molle, V.; Lemaitre Guillier, C.; Vallenet, D.; Pestel Caron, M.; Cozzone, A.; Jouenne, T.; Dé, E. (2005). Channel Formation by CarO, the Carbapenem Resistance-Associated Outer Membrane Protein of Acinetobacter baumannii. Antimicrob. Agents. Chemother. 49 (12), 4876-4883.
26. Sunde, M. (2005). Prevalence and characterization of class 1 and class 2 integrons in Escherichia coli isolated from meat and meat products of Norwegian origin. J. Antimicrob. Chemother. 56 (6), 1019-1024.
27. Takagi, E.; Lincopan, N.; Cassettari, V.; Passadore, L.; Mamizuka, E.; Martinez, M. (2009). Carbapenem-resistant Acinetobacter baumannii outbreak at university hospital. Braz. J. Microbiol. 40 (2), 339-341.
28. Tenover, F.; Arbeit, R.; Goering, R.; Mickelsen, P.; Murray, B.; Pershing, D.; Swaminathan, B. (1995). Interpreting Chromosomal DNA Restriction Patterns Produced by Pulsed-Field Gel Electrophoresis: Criteria for Bacterial Strain Typing. J. Clin. Microbiol. 33 (9), 2233-2239.
29. Thompson, J.; Higgins, D.; Gibson, T. (1994). CLUSTALW: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic. Acids. Res. 22 (22), 4673-4680.
30. Turton, J.; Kaufmann, M.; Warner, M.; Coelho, J.; Dijkshoorn, L.; van der Reijden, T.; Pitt, T. (2004). A prevalent, multiresistant, clone of Acinetobacter baumannii in South East England. J. Hosp. Infect. 58 (3), 170-179.
31. Turton, J.; Ward, M.; Woodford, N.; Kaufmann, M.; Pike, R.; Livermore, D.; Pitt, T. (2006). The role of ISAba1 in expression of OXA carbapenemase genes in Acinetobacter baumannii. FEMS. Microbiol. Lett. 258, 72-77.
32. Villegas, M.; Kattan, J.; Correa, A.; Lolans, K.; Guzman, A.; Woodford, N.; Livermore, D.; Quinn, J. (2007). Dissemination of Acinetobacter baumannii Clones with OXA-23 Carbapenemase in Colombian Hospitals. Antimicrob. Agents. Chemother. 51 (6), 2001-2004.
33. Woodford, N.; Ellington, M.; Coelho, J.; Turton, J.; Ward, M.; Brown, S.; Amyes, S.; Livermore, D. (2006). Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. Internat. J. Antimicrob. Agents. 27, 351-353.
34. Yang, J.; Hsueh, P.; Ko, W.; Luh, K.; Tsai, S.; Wu, H.; Wu, J. (2001). Metallo-b-Lactamases in Clinical Pseudomonas Isolates in Taiwan and Identification of VIM-3, a Novel Variant of the VIM-2 Enzyme. Antimicrob. Agents. Chemother. 45 (8), 2224-2228.